BTAI - BioXcel Therapeutics, Inc.
1.48
-0.130 -8.784%
Share volume: 2,900,127
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.61
-0.13
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-14-2024 | 03-28-2025 | 05-12-2025 | 08-12-2025 | 11-12-2025 | |
| Cash flow financing | 26.626 M | 5.304 M | 454.000 K | 4.276 M | 13.202 M | 137.000 K | 37.532 M | |
| Other financing cash flows | 26.743 M | 5.468 M | 468.000 K | 6.955 M | 14.005 M | -14.006 M | -16.000 K | |
| Cash flow | 8.920 M | 0.000 | 0.000 | 0.000 | 1.159 M | 0.000 | 0.000 | |
| Net income | -26.791 M | -8.299 M | -13.650 M | -10.859 M | -7.254 M | -19.187 M | -30.911 M | |
| Depreciation | 78.000 K | 77.000 K | 77.000 K | 77.000 K | 76.000 K | 75.000 K | 75.000 K | |
| Changes in inventories | 448.000 K | 0.000 | 0.000 | 0.000 | -37.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 8.920 M | -17.870 M | -15.884 M | -10.533 M | 1.159 M | -12.438 M | 18.745 M |